Prosight Management, LP Quant / Systematic

Location: Dallas, TX

CIK: 0001617201 · Show all filings

Period: Q2 2026 (← Previous)

Filing Date: Aug 14, 2026

Total Value: $580M (100.0% shares, 0.0% debt)

Holdings (36)

Increased Positions (16)

IRTC IRHYTHM HOLDINGS INC 3.4%
Value $19.69M (+1568.0%) Shares 165,500 (+1555.0%) Est. Cost Unrealized
GLPG LAKEFRONT BIOTHERAPEUTICS NV 10.6%
Value $61.26M (+31.7%) Shares 2,043,344 (+31.8%) Est. Cost Unrealized
STTK SHATTUCK LABS INC 7.1%
Value $41.35M (+28.5%) Shares 5,957,877 (+19.1%) Est. Cost Unrealized
JANX JANUX THERAPEUTICS INC 10.1%
Value $58.44M (+18.4%) Shares 3,804,481 (+7.2%) Est. Cost Unrealized
SNDX SYNDAX PHARMACEUTICALS INC 4.5%
Value $26.23M (+45.8%) Shares 1,200,000 (+55.8%) Est. Cost Unrealized
ISRG INTUITIVE SURGICAL INC 1.2%
Value $6.761M (+266.6%) Shares 17,000 (+325.0%) Est. Cost Unrealized
ALNY ALNYLAM PHARMACEUTICALS INC 5.1%
Value $29.53M (+17.4%) Shares 98,080 (+29.1%) Est. Cost Unrealized
BSX BOSTON SCIENTIFIC CORP 9.3%
Value $54.22M (+8.6%) Shares 1,270,273 (+59.7%) Est. Cost Unrealized
ZYME ZYMEWORKS INC 3.0%
Value $17.63M (+30.6%) Shares 674,434 (+25.1%) Est. Cost Unrealized
ICUI ICU MED INC 1.3%
Value $7.477M (+110.9%) Shares 51,000 (+85.8%) Est. Cost Unrealized
NKTR NEKTAR THERAPEUTICS 9.7%
Value $56.55M (+6.9%) Shares 810,000 (+10.2%) Est. Cost Unrealized
VEEV VEEVA SYS INC 3.2%
Value $18.85M (+24.1%) Shares 106,200 (+22.8%) Est. Cost Unrealized
ABVX ABIVAX SA 2.5%
Value $14.31M (+22.4%) Shares 107,394 (+2.3%) Est. Cost Unrealized
CRNX CRINETICS PHARMACEUTICALS IN 2.4%
Value $14.02M (+10.3%) Shares 374,666 (+7.0%) Est. Cost Unrealized
RNTX REIN THERAPEUTICS INC 0.2%
Value $1.144M (+113.8%) Shares 1,100,000 (+167.2%) Est. Cost Unrealized
RCKT ROCKET PHARMACEUTICALS INC 0.4%
Value $2.394M (-2.2%) Shares 700,000 (+2.4%) Est. Cost Unrealized

Exited Positions (15)

Decreased Positions (15)

PRCT PROCEPT BIOROBOTICS CORP 1.0%
Value $6.058M (-87.5%) Shares 268,269 (-86.2%) Est. Cost Unrealized
WGS GENEDX HOLDINGS CORP 1.0%
Value $5.87M (-82.5%) Shares 85,500 (-83.7%) Est. Cost Unrealized
ADCT ADC THERAPEUTICS SA 1.4%
Value $8.372M (-73.1%) Shares 7,824,749 (-5.7%) Est. Cost Unrealized
MGTX MEIRAGTX HLDGS PLC 0.2%
Value $1.216M (-94.7%) Shares 90,000 (-96.6%) Est. Cost Unrealized
KURA KURA ONCOLOGY INC 3.8%
Value $22.18M (-18.7%) Shares 2,021,964 (-39.8%) Est. Cost Unrealized
OKUR ONKURE THERAPEUTICS INC 0.8%
Value $4.464M (-49.9%) Shares 978,992 (-54.6%) Est. Cost Unrealized
ALKS ALKERMES PLC 3.6%
Value $20.66M (+13.8%) Shares 394,389 (-23.2%) Est. Cost Unrealized
KIDS ORTHOPEDIATRICS CORP 0.5%
Value $3.013M (-37.2%) Shares 157,500 (-47.9%) Est. Cost Unrealized
EBS EMERGENT BIOSOLUTIONS INC 0.7%
Value $3.854M (-27.3%) Shares 459,952 (-28.0%) Est. Cost Unrealized
TECX TECTONIC THERAPEUTIC INC 0.2%
Value $1.366M (-44.7%) Shares 39,731 (-50.3%) Est. Cost Unrealized
COYA COYA THERAPEUTICS INC 0.2%
Value $995K (-40.0%) Shares 170,000 (-59.6%) Est. Cost Unrealized
PLRX PLIANT THERAPEUTICS INC 0.3%
Value $1.562M (-25.7%) Shares 1,370,233 (-17.8%) Est. Cost Unrealized
ANTX AN2 THERAPEUTICS INC 0.4%
Value $2.297M (+30.2%) Shares 474,638 (-8.0%) Est. Cost Unrealized
IMRX IMMUNEERING CORP 0.0%
Value $184K (-71.7%) Shares 36,861 (-70.1%) Est. Cost Unrealized
CRBP CORBUS PHARMACEUTICALS HLDGS 1.1%
Value $6.097M (-6.9%) Shares 650,000 (-6.8%) Est. Cost Unrealized